Skip to main content

CORRECTION article

Front. Immunol., 15 September 2023
Sec. Vaccines and Molecular Therapeutics
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1292349

Expression of concern on: Immunoreactivity of sera from low to moderate malaria-endemic areas against plasmodium vivax rPvs48/45 proteins produced in Escherichia coli and Chinese hamster ovary systems

This article is a correction to:

  1. Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems

    1. Read original article
Frontiers Editorial Office* Frontiers Editorial Office*

    An expression of concern on
    Immunoreactivity of sera from low to moderate malaria-endemic areas against plasmodium vivax rPvs48/45 proteins produced in Escherichia coli and Chinese hamster ovary systems

    by Arévalo-Herrera M, Miura K, Cespedes N, Echeverry C, Solano E, Castellanos A, Ramirez JS, Miranda A, Kajava AV, Long C, Corradin G and Herrera S (2021) Front. Immunol. 12:634738. doi: 10.3389/fimmu.2021.634738

    With this notice, Frontiers states its awareness of serious allegations surrounding the institutional review board Centro Internacional de Vacunas cited in this article. These allegations are being investigated in line with COPE guidelines. The situation will be updated as soon as the investigation is complete.

    Citation: Frontiers Editorial Office (2023) Expression of concern on: Immunoreactivity of sera from low to moderate malaria-endemic areas against plasmodium vivax rPvs48/45 proteins produced in Escherichia coli and Chinese hamster ovary systems. Front. Immunol. 14:1292349. doi: 10.3389/fimmu.2023.1292349

    Received: 11 September 2023; Accepted: 11 September 2023;
    Published: 15 September 2023.

    Approved by:

    Frontiers Editorial Office, Frontiers Media SA, Switzerland

    Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    *Correspondence: Frontiers Editorial Office, search.integrity@frontiersin.org

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.